Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease
Clinical trial NCT03363269 · COMPLETED
Trial details
- NCT number
- NCT03363269
- Sponsor
- IlDong Pharmaceutical Co Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-12
- Primary completion
- 2018-12-31
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.